Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non-alcoholic steatohepatitis].

Héctor Alvarez-Martínez1, Eduardo Pérez-Campos

  • 1Hospital Regional Presidente Juárez, ISSSTE, Oaxaca, Oax. heloy_57@yahoo.com.mx

Revista De Gastroenterologia De Mexico
|September 7, 2002
PubMed
Summary

Non-alcoholic steatohepatitis (NASH) is a serious liver condition linked to obesity and dyslipidemia. Early detection and management, including weight control and metabolic normalization, are crucial to prevent progression to cirrhosis or liver cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic signals are not equal clinical phenotypes: redefining evidence standards in arbovirus-SARS-CoV-2 cross-reactivity.

Frontiers in immunology·2026
Same author

Probiotics in irritable bowel syndrome: strain-specific effects, diet, and biomarker timing.

Frontiers in cellular and infection microbiology·2026
Same author

Oxidative dyslipidemia in early pregnancy: integrating atherogenic index of plasma (AIP) and uric acid (UA) to refine preeclampsia risk stratification.

Frontiers in pharmacology·2026
Same author

Microbial Genomic Consortia in Prostate Cancer: Mechanistic Signaling, the Gut-Prostate Axis, and Translational Perspectives.

Cancers·2026
Same author

Ischemic Heart Disease and the Epidemiologic Transition: Progress without Reduction in Global Burden.

Discoveries (Craiova, Romania)·2026
Same author

Preventable mortality in Mexico: bridging gaps in chronic disease and ageing care.

BMJ global health·2026

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Non-alcoholic steatohepatitis (NASH) is a chronic liver disease in individuals with minimal alcohol intake.
  • Histologically, NASH shares features with alcoholic hepatitis, including steatosis, hepatocellular necrosis, inflammation, and fibrosis, with Mallory bodies in some cases.
  • NASH is increasingly recognized as a serious condition with potential progression to liver cirrhosis and hepatocellular carcinoma.

Purpose of the Study:

  • To provide a comprehensive overview of Non-alcoholic steatohepatitis (NASH).
  • To discuss the multifactorial origins, clinical presentation, diagnostic methods, and current treatment strategies for NASH.
  • To highlight the evolving understanding of NASH from a benign condition to a potentially severe liver disease.

Main Methods:

  • Review of existing literature and clinical observations on NASH.
  • Analysis of histological features and associated risk factors.
  • Discussion of diagnostic procedures, primarily liver biopsy.
  • Overview of current therapeutic approaches focusing on lifestyle and metabolic management.

Main Results:

  • NASH is associated with female sex, obesity, and dyslipidemia, but affects diverse populations.
  • Potential contributing factors include insulin resistance, protein glycation, and oxidative stress.
  • The disease can be asymptomatic, often discovered incidentally through elevated aminotransferases.
  • Liver biopsy remains the gold standard for definitive diagnosis.

Conclusions:

  • NASH is a significant health concern with multifactorial etiology.
  • Effective management involves weight control, normalization of glucose and lipid levels, and potentially medication.
  • Prompt diagnosis and intervention are essential to mitigate the risk of severe liver complications like cirrhosis and cancer.

Related Experiment Videos